Powerful Diagnostic Testing
Quidel Sofia, Triage MeterPro,
and Solana assays and instruments
offer fast and accurate results
when you need them most.
The Quidel™ Sofia™ 2 Analyzer and test kits use fluorescent immunoassay (FIA) to help you detect:
• Influenza A and B antigens from swab and wash samples (CLIA Waived)
• SARS-CoV-2 nucleocapsid protein antigens from swabs (CLIA Moderate)
• Lyme disease antibodies (human IgM and IgG to Borrelia burgdorferi, CLIA Moderate)
The Quidel™ Triage™ MeterPro combines sophisticated technology with user-friendly ergonomics to deliver high-performance testing in the laboratory or at the point of care.
Accelerate decision-making for cardiac conditions by quantitatively measuring levels of B-type natriuretic peptide or BNP in EDTA whole blood or plasma. Or qualitatively test for the presence of drugs or major metabolites of up to nine drug classes (amphetamines, barbiturates, benzodiazepines, cocaine, methadone, methamphetamine, opiates, THC, and tricyclic antidepressants).
The Quidel™ Solana™ platform makes molecular diagnostic testing faster and easier without sacrificing performance. Quidel’s proprietary methods (helicase-dependent amplification with fluorescence detection) deliver reliable Streptococcus, HSV, VZV, RSV, and hMPV results in less than an hour without the need for a thermal cycler.
The Quidel™ QuickVue™ line of products has been serving hospital and physician office labs for more than 30 years and continues to deliver quality results with a variety of formats well suited for both POC and laboratory needs. Count on QuickVue rapid lateral flow tests for quick, accurate results that allow for faster diagnosis and treatment.
Savanna™ is a compact benchtop instrument that utilizes real-time PCR to deliver automated customized molecular results in minutes.
Provides accurate and easy-to-interpret results in 12 minutes or less
Uses a monoclonal antibody specific to the beta subunit of hCG in a single-step technology
Features rapid method of nucleic acid amplification that does not require thermal cycler. For qualitative detection of Group A β-hemolytic Streptococcus (Streptococcus pyogenes), and pyogenic Group C/G (streptococcus dysgalactiae) nucleic acids.
Detects SARS-CoV-2 antigens directly from anterior nares swab specimens. The QuickVue SARS Antigen Test provides accurate and reliable results in 10 minutes.
Aids in the rapid differential diagnosis of acute influenza A and B virus infection
The Solana RSV + hMPV Assay is a rapid qualitative in vitro diagnostic test for the detection and differentiation of Respiratory Syncytial Virus (RSV) and Human Metapneumovirus (hMPV) viral RNA in nasal and nasopharyngeal swabs from patients with signs and symptoms of respiratory infection.
Uses immunofluorescence-based lateral flow technology in a sandwich design for qualitative detection of nucleocapsid protein from SARS-CoV-2. Provides automated and objective results in 15 minutes, allowing for testing of patients suspected of COVID-19/2019-nCoV in near-patient testing environments.
The Quickvue™ At-Home OTC COVID-19 test can accurately detect the Omicron variant (among others) of the Sars-CoV-2, the potentially deadly virus that can lead to COVID-19.
For rapid qualitative detection of Group A Streptococcal antigens from throat swabs of symptomatic patients
Immunochemical FOB test—a more analytically sensitive alternative to Guiac methods
For use with QuickVue Dipstick Strep A test and QuickVue+ Strep A kit only.
For rapid, qualitative detection of RSV antigen directly from nasopharyngeal swab or aspirate specimens from symptomatic pediatric patients
Detects Group A Streptococcal antigen directly from patient throat swab specimens or confirms presumptive Group A Streptococcal colonies recovered from culture. Used as an aid in the diagnosis of Group A Streptococcal infection. Lateral flow immunoassay, using Quidel's patented assay device.
